Skip to main content
. 2023 Apr 25;2023:4223026. doi: 10.1155/2023/4223026

Table 3.

Effect of CLHE and CFHE on TC, LDL-C, HDL-C, TAGs, VLDL-C, and FFAs levels among the study groups.

Group (n = 6) TC (mg/dL) LDL-C (mg/dL) HDL-C (mg/dL) TAGs (mg/dL) VLDL-C (mg/dL) FFAs (nmole/L)
Negative control 50.50 ± 2.08d 18.55 ± 1.62d 27.5 ± 1.20a 26.18 ± 2.25d 5.24 ± 0.44d 16.10 ± 0.37b
Diabetic control 114.33 ± 8.33a 84.43 ± 14.50a 22.52 ± 1.57c 45.93 ± 2.21a 9.20 ± 0.45a 44.43 ± 6.07a
Diabetic treated with CLHE 92.66 ± 11.52b 59.65 ± 13.69b 25.03 ± 1.62b 35.1 ± 3.70b 6.91 ± 0.71b 42.88 ± 2.99a
Diabetic treated with CFHE 62.00 ± 5.41c 32.4 ± 6.49c 23.53 ± 1.64c 30.33 ± 1.20c 6.1 ± 0.27c 40.10 ± 3.19a

Data were expressed as mean ± SD. For each variable, values that do not share the same superscript letter (a, b, c, and d) were significantly different at p < 0.05. TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TAGs, triglycerides; VLDL-C, very-low-density lipoprotein-cholesterol; FFAs, free fatty acids; CLHF, C. scolymus leaf hydroethanolic extract; CFHE, C. scolymus flower hydroethanolic extract.